Bayer stops trial of drug it hopes will be a blockbuster

Bayer has halted testing for vilaprisan, a new medication developed to treat uterine fibroids. The company said that it ’s concerned about the risk of side effects uncovered in toxicology data.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Toxicology